Cargando…
Covid-19, ocular manifestation and ophthalmic risks
Autores principales: | Joob, B., Wiwanitkit, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275176/ https://www.ncbi.nlm.nih.gov/pubmed/32553398 http://dx.doi.org/10.1016/j.jfo.2020.04.021 |
Ejemplares similares
-
Ocular manifestations of sickle cell disease
por: Joob, Beuy, et al.
Publicado: (2018) -
COVID-19: Ocular Manifestations and the APAO Prevention Guidelines for Ophthalmic Practices
por: Wong, Raymond L.M., et al.
Publicado: (2020) -
The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020) -
Ocular manifestation, eye protection, and COVID-19
por: Mungmungpuntipantip, Rujittika, et al.
Publicado: (2020) -
Ocular Manifestations in Hemodialysis Patients: Importance of Ophthalmic Examination in Prevention of Ocular Sequels
por: Kianersi, Farzan, et al.
Publicado: (2019)